Leukaemia Foundation

Leukaemia, Lymphoma, Myeloma & Related Blood Disorders.

Change Your Location:

2005 Grant Recipients

PhD Scholarships

2005 - 2007

 Area of Research 

per annum

Mr L. Ellis Peter MacCallum Cancer Centre, VIC

Assessing apoptotic and therapeutic properties of histone deacytelase inhibitors in mouse cancer models (LYMPHOMA) | more

Final Report 2007

 $40,000

Ms J. Freeman
Mater Medical Research Institute, QLD

Validation of potential multiple myeloma tumour antigens for blood dendritic cell immunotherapy (MM) | more

Final Report 2007

 $40,000

Mr A. Hsu
Mater Medical Research Institute, QLD

Proof of principle for use of CTL induced by RNA loaded 34 + SC derived DC to eradicate leukaemia post transplant (LEUKAEMIA) | more

Final Report 2007

 $40,000

Ms C. Modra
Mater Medical Research Institute, QLD

Potential new target molecules for acute myeloid leukaemia treatment - role of 35-L5 molecule (AML) | more

 $40,000

 

Post-Doctoral Fellowships
2005-2007

   

Dr A. Brown
Child Health Research Institute, SA

A new approach for identifying cancer-causing genes involved in leukaemia (LEUKAEMIA) | more

Final Report 2005

 $88,900

Dr W. Cook (Greg Johnson Memorial Fellowship)
University of Melbourne

The role of stress activated cell signaling proteins in leukaemia (LEUKAEMIA) | more

 $75,000

 

Clinical Fellowship
2005 - 2007

   

Dr K. Micklethwaite
Westmead Institute for Cancer Research, NSW

Prevention of infections after bone marrow transplant using donor immune cells (BONE MARROW TRANSPLANT)

Final Report 2007

 $98,900

Dr K. Herbert
(Max Whiteside Clinical Fellowship)
Peter MacCallum Cancer Centre, VIC

Retinoids and their applications to human stem cell mobilization (STEM CELL TRANSPLANTATION) | more

 $80,000

 

Grants-in-Aid 
2005

   

Prof L. Ashman
University of Newcastle, NSW

Mechanisms of drug resistance in acute myeloid leukaemia (AML)

Final Report 2005

 $78,000

Prof D. Hart et alMater Medical Research Institute, QLD

Purified blood DC vaccination with defined tumour associate antigens for multiple myeloma (MM) | more

 $80,000

Dr G. Hill & Dr A. Nicol
QLD Institute of Medical Research

Prevention of leukaemia relapse after stem cell transplantation (STEM CELL TRANSPLANTATION)

Final Report 2005

 $80,000

Ms K. Laird, Dr L. Monterosso & Ms K. Johnson
Princess Margaret Hospital, WA

Following treatment of cancer, do children return to normal activity levels?

 $10,000

Assoc Prof M. Kavallaris, Dr R. LockChildren's Cancer Institute Australia, NSW (2005 - 2007)

Glucocorticoid resistance mechanisms in childhood acute lymphoblastic leukaemia (ALL) | more

Final Report 2007

 $88,832

Assoc Prof J. Matthews, Assoc Prof J. Mackay, Prof M. Crossley
The University of Sydney (2005 - 2007)

Development of reagents treat T-cell leukaemias (LEUKAEMIA)

Final Report 2007

 $90,000

Dr P. Mollee
Princess Alexandra Hospital, QLD

A phase-II study of risk-adapted IV melphalan in patients with AL amyloidosis (AMYLOIDOSIS) | more

 $30,000

Prof J. Rasko
Centenary Institute of Cancer Medicine and Cell Biology, NSW

Understanding a new class of gene expression regulators implicated in leukaemia (GENE AND STEM CELL THERAPY) | more

Final Report 2005

 $90,000

Dr G. Suthers et al
Various institutions in VIC and SA

The Australian Familial Haematological Cancer Study (GENETIC PREDISPOSITIONS) | more

Final Report 2005

 $30,000

 

Honours Scholarships 
2005

   

Ms J. Bird
James Cook University, QLD

The development of inhibitors of Bcl-2-family proteins as potential therapeutic agents in leukaemia and lymphoma (LEUKAEMIA AND LYMPHOMA)

Final Report 2005

 $10,000

Ms K. Jarman
Child Health Research Institute, SA

Investigating the role and requirement of beta-catenin in haematopoiesis

Final Report 2005

 $10,000

Ms C. King
Peter MacCallum Cancer Centre, VIC

The role of Rb and Id2 in erythropoiesis

Final Report 2005

$10,000 

Mr E. Ko Peter MacCallum Cancer Centre, VIC

Study of the role of protein p202 in the division and maturation of myeloid cells (LEUKAEMIA)

Final Report 2005

 $10,000